Chemoinformaics analysis of 5-(3,4-DIMETHOXYPHENYL)-6H-[2]BENZOFURO[6,5-F][1,3]BENZODIOXOL-8-ONE
| Molecular Weight | 364.353 | nRot | 3 |
| Heavy Atom Molecular Weight | 348.225 | nRig | 26 |
| Exact Molecular Weight | 364.095 | nRing | 5 |
| Solubility: LogS | -6.273 | nHRing | 2 |
| Solubility: LogP | 4.142 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 3 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 50.5507 |
| nHD | 0 | BPOL | 25.5993 |
| QED | 0.657 |
| Synth | 2.499 |
| Natural Product Likeliness | 0.847 |
| NR-PPAR-gamma | 0.023 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.225 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -5.045 |
| MDCK | 0.0000662 |
| BBB | 0.108 |
| PPB | 0.935836 |
| VDSS | 0.954 |
| FU | 0.0168731 |
| CYP1A2-inh | 0.938 |
| CYP1A2-sub | 0.812 |
| CYP2c19-inh | 0.976 |
| CYP2c19-sub | 0.136 |
| CYP2c9-inh | 0.821 |
| CYP2c9-sub | 0.937 |
| CYP2d6-inh | 0.777 |
| CYP2d6-sub | 0.936 |
| CYP3a4-inh | 0.897 |
| CYP3a4-sub | 0.197 |
| CL | 12.423 |
| T12 | 0.293 |
| hERG | 0.092 |
| Ames | 0.663 |
| ROA | 0.075 |
| SkinSen | 0.413 |
| Carcinogencity | 0.889 |
| EI | 0.048 |
| Respiratory | 0.501 |
| NR-Aromatase | 0.719 |
| Antiviral | Yes |
| Prediction | 0.863364 |